DEPArray Overview from Silicon Biosystems
11 Feb 2016
Silicon Biosystems has combined the ability to manipulate individual cells using Dielectrophoresis (DEP) technology with high quality image-based cell selection to create the DEPArray™ System. This automated platform enables users to identify and recover specific individual cells of interest from complex, heterogeneous samples.
About the company

Silicon Biosystems
Silicon Biosystems has developed a set of proprietary solutions called lab-on-a-chip technologies, targeted at miniaturized cell-biology testing. Silicon Biosystems exploits the microelectronics potential in order to produce miniaturized cellular biology laboratories. The approach patented by Silicon Biosystems has given rise to an unprecedented technology platform able to perform complex protocols, since it offers the unique possibility of controlling individual cells and micro-particles inside a micro-chamber. Silicon Biosystems technology individually manages more than 100,000 cells on a single microelectronic chip, using software control and incorporating sensors to detect the results of complex procedures. The company has a reputation for being one of the most innovative start-ups in the field of ?ab-on-a-chip?based on active substrates, as testified by a number of awards and recognitions. Silicon Biosystems is also an industrial member of the nano2Life EC Network of Excellence on nanobiotechnologies.